Elsevier Wins Five First Prizes at BMA Medical Book Awards Competition

Elsevier congratulates its award-winning medical authors and editors for consistently producing high-quality medical content

Philadelphia, PA, September 26, 2013

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announced today that 25 of its professional and scholarly products were honored at the British Medical Association's annual BMA Medical Book Awards ceremony at BMA House in London on September 17, 2013. This year publishers submitted more than 640 products, and the BMA awarded 122 prizes, with 21 first prizes and 101 highly commended prizes.

"We congratulate all of the winners and especially thank all of the authors, editors and Elsevier publishing staff who have worked on these prize-winning titles," said Linda Belfus, Senior Vice President at Elsevier. "This is an amazing achievement and reflects our dedication to developing and delivering quality content."

Elsevier received First prizes in the following categories:

"We are really delighted to receive this award on behalf of our authors, our Elsevier editorial team and our digital partners at Inkling," said Parveen Kumar, CBE, BSc, MD, DM (HC), FRCP, FRCP (Edin), co-author of Kumar & Clark's Clinical Medicine. "The whole team worked very hard to create an engaging, multimedia interface to the demanding content of this book in order to accommodate all learning styles and improve the student experience. We all very much appreciate this wonderful endorsement from the BMA."

Dr. Kumar attended the ceremony, as did Anthony du Vivier, MD, FRCP, author of Atlas of Clinical Dermatology.

"I'm absolutely delighted with the BMA tribute and was helped by a brilliant team at Elsevier to pull it all together," said Dr. du Vivier. "Many thanks to my editors Russell Gabbedy and Sharon Nash."

Elsevier also received Highly Commended prizes in the following categories:

 For more information about the awards, please visit the BMA website

# # #

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions — among them ScienceDirect, Scopus, Elsevier Research Intelligence, and ClinicalKey — and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.

The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).

Media contact
Christopher Capot
Director, Corporate Relations
Elsevier
+1 212 633 3164
c.capot@elsevier.com